Solvent CR

Solvent's Cash & Cash Equivalents fell 29.2% yoy to CZK 113 mil in 2016

By Helgi Analytics - April 2, 2020

Solvent CR's total assets reached CZK 5,630 mil at the end of 2016, up 10.5% compared to the previous year. Curren...

Profit Statement 2014 2015 2016
Sales CZK mil 6,928 7,702 8,707
Gross Profit CZK mil 921 1,086 1,224
EBITDA CZK mil 524 679 679
EBIT CZK mil 400 500 444
Financing Cost CZK mil 36.9 56.4 53.6
Pre-Tax Profit CZK mil 304 379 335
Net Profit CZK mil 162 262 249
Balance Sheet 2014 2015 2016
Total Assets CZK mil 4,097 5,096 5,630
Non-Current Assets CZK mil 1,244 1,490 1,776
Current Assets CZK mil 2,741 3,409 3,644
Working Capital CZK mil 1,664 2,769 3,079
Shareholders' Equity CZK mil 2,341 2,459 2,742
Liabilities CZK mil 1,756 2,637 2,888
Total Debt CZK mil 1,053 888 1,305
Net Debt CZK mil 966 729 1,192
Ratios 2014 2015 2016
ROE % 7.30 10.9 9.58
ROCE % 5.78 7.32 5.47
Gross Margin % 13.3 14.1 14.1
EBITDA Margin % 7.57 8.82 7.80
EBIT Margin % 5.78 6.49 5.09
Net Margin % 2.33 3.41 2.86
Net Debt/EBITDA 1.84 1.07 1.76
Net Debt/Equity % 41.3 29.6 43.5
Cost of Financing % 3.41 5.81 4.88
Cash Flow 2014 2015 2016
Cash Conversion Cycle days 98.0 144 143
Cash Earnings CZK mil 286 442 484

Get all company financials in excel:

Download Sample   $19.99

summary Unit 2009 2010 2011 2012 2013 2014 2015 2016
income statement                
Sales CZK mil   4,711 4,692 5,590 6,421 6,928    
Gross Profit CZK mil   447 422 380 575 921    
EBIT CZK mil   315 317 270 432 400    
Net Profit CZK mil   202 192 197 160 162    
ROE %   18.2 14.2 12.5 8.48 7.30    
EBIT Margin %   6.69 6.75 4.83 6.72 5.78    
Net Margin %   4.29 4.10 3.52 2.49 2.33    
Employees   1,217 1,259 1,946 2,030 2,229    
balance sheet                
Total Assets CZK mil   1,800 1,944 3,196 3,712 4,097    
Non-Current Assets CZK mil   497 508 860 1,110 1,244    
Current Assets CZK mil   1,289 1,412 2,164 2,475 2,741    
Shareholders' Equity CZK mil   1,231 1,482 1,681 2,084 2,341    
Liabilities CZK mil   569 462 1,515 1,628 1,756    
Non-Current Liabilities CZK mil   17.8 18.0 337 355 408    
Current Liabilities CZK mil   325 374 649 590 696    
Net Debt/EBITDA   0.553 0.036 2.30 1.90 1.84    
Net Debt/Equity %   16.2 0.854 44.1 47.5 41.3    
Cost of Financing % ... 3.35 3.12 0.966 3.30 3.41    
income statement Unit 2009 2010 2011 2012 2013 2014 2015 2016
income statement                
Sales CZK mil   4,711 4,692 5,590 6,421 6,928    
Cost of Goods & Services CZK mil   4,264 4,270 5,210 5,846 6,008    
Gross Profit CZK mil   447 422 380 575 921    
Staff Cost CZK mil   389 391 520 553 664    
Other Cost CZK mil   -303 -323 -462 -499 -268    
EBITDA CZK mil   361 354 323 521 524    
Depreciation CZK mil   46.5 37.4 52.6 89.1 124    
EBIT CZK mil   315 317 270 432 400    
Financing Cost CZK mil   13.2 5.89 4.92 33.2 36.9    
Extraordinary Cost CZK mil   26.3 50.5 -19.9 139 59.6    
Pre-Tax Profit CZK mil   275 260 285 260 304    
Tax CZK mil   60.7 54.2 63.0 69.4 99.7    
Minorities CZK mil   12.6 13.9 24.9 30.9 42.5    
Net Profit CZK mil   202 192 197 160 162    
growth rates                
Total Revenue Growth % ... 15.6 -0.398 19.1 14.9 7.90    
Operating Cost Growth % ... -27.3 -20.2 -15.3 -5.17 624    
EBITDA Growth % ... 84.0 -2.01 -8.91 61.4 0.683    
EBIT Growth % ... 97.2 0.580 -14.8 59.9 -7.26    
Pre-Tax Profit Growth % ... 111 -5.48 9.46 -8.81 16.9    
Net Profit Growth % ... 106 -4.88 2.45 -19.0 1.23    
ratios                
ROE %   18.2 14.2 12.5 8.48 7.30    
ROCE % ... 14.5 13.2 10.3 6.34 5.78    
Gross Margin %   9.49 9.00 6.80 8.96 13.3    
EBITDA Margin %   7.67 7.55 5.77 8.11 7.57    
EBIT Margin %   6.69 6.75 4.83 6.72 5.78    
Net Margin %   4.29 4.10 3.52 2.49 2.33    
Cost of Financing % ... 3.35 3.12 0.966 3.30 3.41    
Net Debt/EBITDA   0.553 0.036 2.30 1.90 1.84    
balance sheet Unit 2009 2010 2011 2012 2013 2014 2015 2016
balance sheet                
Non-Current Assets CZK mil   497 508 860 1,110 1,244    
Property, Plant & Equipment CZK mil   500 510 802 1,045 1,188    
Intangible Assets CZK mil   -4.25 0.792 6.06 12.2 13.9    
Current Assets CZK mil   1,289 1,412 2,164 2,475 2,741    
Inventories CZK mil   807 886 1,442 1,655 1,766    
Receivables CZK mil   273 243 310 372 389    
Cash & Cash Equivalents CZK mil   64.4 101 162 122 87.4    
Total Assets CZK mil   1,800 1,944 3,196 3,712 4,097    
Shareholders' Equity CZK mil   1,231 1,482 1,681 2,084 2,341    
Of Which Minority Interest CZK mil   31.3 36.1 70.1 107 153    
Liabilities CZK mil   569 462 1,515 1,628 1,756    
Non-Current Liabilities CZK mil   17.8 18.0 337 355 408    
Long-Term Debt CZK mil   17.8 18.0 337 355 408    
Deferred Tax Liabilities CZK mil   0 0 0 0 0    
Current Liabilities CZK mil   325 374 649 590 696    
Short-Term Debt CZK mil   246 95.6 567 756 645    
Trade Payables CZK mil   145 146 265 450 492    
Provisions CZK mil   4.18 3.97 5.28 4.50 141    
Equity And Liabilities CZK mil   1,800 1,944 3,196 3,712 4,097    
growth rates                
Total Asset Growth % ... -0.076 8.01 64.4 16.1 10.4    
Shareholders' Equity Growth % ... 24.4 20.5 13.4 24.0 12.3    
Net Debt Growth % ... -51.1 -93.7 5,757 33.4 -2.36    
Total Debt Growth % ... -49.7 -57.0 696 23.0 -5.24    
ratios                
Total Debt CZK mil   264 114 904 1,111 1,053    
Net Debt CZK mil   200 12.7 742 989 966    
Working Capital CZK mil   936 983 1,488 1,577 1,664    
Capital Employed CZK mil   1,432 1,491 2,347 2,686 2,908    
Net Debt/Equity %   16.2 0.854 44.1 47.5 41.3    
Cost of Financing % ... 3.35 3.12 0.966 3.30 3.41    
cash flow Unit 2009 2010 2011 2012 2013 2014 2015 2016
cash flow                
Net Profit CZK mil   202 192 197 160 162    
Depreciation CZK mil   46.5 37.4 52.6 89.1 124    
ratios                
Days Sales Outstanding days   21.1 18.9 20.2 21.1 20.5    
Days Sales Of Inventory days   69.1 75.7 101 103 107    
Days Payable Outstanding days   12.4 12.5 18.5 28.1 29.9    
Cash Conversion Cycle days   77.9 82.2 103 96.4 98.0    
Cash Earnings CZK mil   249 230 250 249 286    
other data Unit 2009 2010 2011 2012 2013 2014 2015 2016
other data                
ROA %   11.2 10.3 7.67 4.62 4.14    
Gross Margin %   9.49 9.00 6.80 8.96 13.3    
Employees   1,217 1,259 1,946 2,030 2,229    
Cost Per Employee USD per month   1,392 1,464 1,139 1,161 1,162    
Cost Per Employee (Local Currency) CZK per month   26,606 25,889 22,271 22,712 24,829    
Staff Cost (As % Of Total Cost) %   8.84 8.94 9.78 9.24 10.2    
Effective Tax Rate %   22.0 20.8 22.1 26.7 32.8    

Get all company financials in excel:

Download Sample   $19.99

Solvent CR s.r.o. is a Czech Republic-based drug store chain. It operates 700 drug retail outlets under the brand name TETA. The company was founded in 1992 and is based in Sestajovice, Czech Republic.

Finance

Solvent CR has been growing its sales by a year on average in the last 5 years. EBITDA has grown on average by 13.9% a year during that time to total of CZK 679 mil in 2016, or 7.80% of sales. That’s compared to 7.61% average margin seen in last five years.

The company netted CZK 249 mil in 2016 implying ROE of 9.58% and ROCE of 5.47%. Again, the average figures were 9.75% and 7.04%, respectively when looking at the previous 5 years.

Solvent CR’s net debt amounted to CZK 1,192 mil at the end of 2016, or 43.5% of equity. When compared to EBITDA, net debt was 1.76x, down when compared to average of 1.77x seen in the last 5 years.